Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) General Information

Description

A portfolio of two drug assets and their associated intellectual property, formulations, clinical data, and commercial rights.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Toronto, Ontario
  • Canada
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • Toronto, Ontario
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada)‘s full profile, request access.

Request a free trial

Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada)‘s full profile, request access.

Request a free trial

Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) FAQs

  • Where is Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) headquartered?

    Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) is headquartered in Toronto, Canada.

  • What industry is Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) in?

    Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada)’s primary industry is Buildings and Property.

  • Is Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) a private or public company?

    Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) is a Private company.

  • What is the current valuation of Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada)?

    The current valuation of Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) is .

  • What is Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada)’s current revenue?

    The current revenue for Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) is .

  • Who are Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada)’s investors?

    Galera Therapeutics has invested in Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada).

  • When was Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) acquired?

    Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) was acquired on 22-Oct-2025.

  • Who acquired Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada)?

    Galera Therapeutics (Dismutase Mimetics Portfolio in Toronto, Canada) was acquired by Biossil.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process